title: Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: preliminary results.
abstract: The response of psoriasis and cutaneous T-cell lymphoma to treatment with 8-methoxypsoralen (8-MOP) and long wavelength ultraviolet light (UVA) is only partly understood. Psoralens form photoadducts within the DNA after activation by UVA and this damage leads to the inhibition of DNA synthesis. Additionally, it has been shown that different forms of DNA damage can induce a stress response, leading to upregulation of selected products. Among these are the major histocompatibility complex (MHC) class I genes. Thus the aim of the present study was to assess the rate of synthesis of MHC class I proteins in murine T-cell lymphoma cells (RMA) after treatment with 8-MOP and UVA. RMA cells were treated with 8-MOP (50-200 ng ml-1) and UVA (1 J.cm-2) and metabolically labelled with 35S-methionine 4 and 24 h after treatment. MHC class I synthesis was determined by immunoprecipitation of the cell lysates with an anti-Kb monoclonal antibody, Y3. After 4 h, treated and untreated cells demonstrated no differences in the rate of MHC class I synthesis. However, after 24 h a dose-dependent increase in MHC class I synthesis was observed. This increase in MHC class I expression could be responsible, at least partly, for the responses observed in patients treated with photopheresis.
mesh_terms: D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D004305:Dose-Response Relationship, Drug; D015870:Gene Expression / Q000187:drug effects / Q000528:radiation effects; D015395:Histocompatibility Antigens Class I / Q000096:biosynthesis*; D007700:Kinetics; D016399:Lymphoma, T-Cell / Q000276:immunology*; D008730:Methoxsalen / Q000494:pharmacology* / Q000528:radiation effects; D051379:Mice; D017319:Photosensitizing Agents / Q000494:pharmacology*; D013997:Time Factors; D014407:Tumor Cells, Cultured; D014466:Ultraviolet Rays
chemical_list: D015395:Histocompatibility Antigens Class I; D017319:Photosensitizing Agents; D008730:Methoxsalen